Antimony, Resources

Antimony Resources Holds Its Breath for Central Zone Assays After a Vicious Sell-Off

Published on 07/19/2026 at 13:43 | Redaktion boerse-global.de

Antimony Resources stock plunges 75% from peak, hits oversold RSI. Pending assay results from Bald Hill's Central Zone could spark rebound, but financing risks and dilution fears weigh.

Antimony Resources Shares Down 75%, Awaiting Key Assay Results
Antimony Resources Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

A technical oversold reading, a 75% wipeout from the March peak, and a set of assay results expected any day now – Antimony Resources is staring down a defining week. The explorer behind the Bald Hill antimony project in New Brunswick has seen its shares shed nearly a quarter of their value in the past seven sessions, closing Friday at €0.2630, down a further 5.05%. On a monthly basis, the stock is off 34.41%.

The scale of the retreat can be measured against the 52-week highs: on 17 March 2026 the stock touched €1.05, a level it now sits 75% below. Yet the longer-term picture still shows a 120.27% gain over the past twelve months, and investors who bought the July 2025 trough at €0.1150 are still sitting on comfortable profits. The 14-day relative strength index has sunk to 30.1, a zone that traders typically regard as oversold and suggestive of exhausted selling pressure. Both the 50-day moving average (€0.4351) and the 200-day moving average (€0.4712) lie well above the current price, while annualized 30-day volatility of 111.7% underlines the violent swings typical of a high-risk resource stock.

The immediate focus for the market is the pending batch of assay results from the newly identified Central Zone at Bald Hill. In an update on 6 July, management said it had completed over 2,000 metres of drilling there, targeting mineralisation already exposed in surface trenches. Samples were dispatched to the lab at that time, with results expected roughly two weeks later – putting delivery squarely in the coming days. The larger programme in the Main Zone, comprising some 18,000 metres, is meanwhile continuing to expand known mineralisation to the south, north and at depth as the company builds toward an initial resource estimate.

Should investors sell immediately? Or is it worth buying Antimony Resources?

Past intercepts from the Main Zone have returned eye-catching grades – up to 33.40% antimony in one hole, and 16.65% and 13.14% in others. High-grade hits from the Central Zone could provide a much-needed catalyst for the beaten-down share price. That said, a number of market participants are beginning to worry less about grades and more about financing risks. The stock’s steep decline has fuelled talk of potential dilution, and the company has not yet detailed how it intends to fund the rest of its 2026 exploration programme.

Beyond the drilling, Antimony Resources is also shoring up its political and strategic ties. Earlier this month it appointed John M. Melkon to its advisory board. Melkon, a lecturer at the United States Military Academy since 2012, now directs the academy’s Critical Minerals Consortium, an initiative that aligns directly with Washington’s push to secure domestic supplies of antimony. The metal is essential for hardening ammunition, manufacturing flame retardants and producing night-vision equipment, and the US currently produces virtually none of it. China’s recent export restrictions have sent prices soaring and turned reliable access into a national security concern.

CEO Jim Atkinson said the company looks forward to introducing itself to the US Department of Defense through Melkon’s connections, with the ultimate aim of securing offtake agreements and federal loans or grants – including potential support from the Export-Import Bank – for the Bald Hill project. The timing of this strategic push coincides with a broader re-evaluation of antimony supply chains, keeping the project firmly on Washington’s radar even as the equity market delivers a harsh verdict on the stock.

No quarterly earnings or shareholder meetings are imminent, leaving the near-term narrative in the hands of two factors: whether the oversold technical condition can lure bargain hunters, and whether the Central Zone assays deliver the kind of grade that can reverse the prevailing sentiment. Given the extreme volatility, sharp moves in either direction are likely until fresh drilling data – or news on the financing front – provides a clearer signal.

Ad

Antimony Resources Stock: New Analysis - 19 July

Fresh Antimony Resources information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Antimony Resources analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | CA0369271014 | ANTIMONY | boerse | 69804313 |